Z/3A4#WK%83|LY:<A,2;*:9RN9V
SYSTEM PROCESSING...
Z/3A4#WK%83|LY:<A,2;*:9RN9V
SYSTEM PROCESSING...
Posted: 2025-04-24 04:51:27 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 04:53:44 UTC
Verified By
Rollup News
An individual patient data analysis of the REVIVED-BCIS2 and STICHES trials, published in the European Heart Journal, indicates that patients receiving medical therapy in REVIVED-BCIS2 had a lower risk of death or hospitalization for heart failure than those enrolled in STICHES.
Patients receiving medical therapy in REVIVED-BCIS2 had a lower risk of death or hospitalization for heart failure compared to those in STICHES.
Advances in medical therapy have improved outcomes for patients with ischaemic cardiomyopathy.
Further trials of coronary revascularization in patients with ischaemic cardiomyopathy are needed.
Determining the optimal treatment strategies for patients with ischaemic left ventricular dysfunction.
Limiting the clinical actionability of previous trials in light of advances in medical therapy.